NAVB - Navidea Biopharmaceuticals Inc
Previous close
0.001
0 0%
Share volume: 1,836,193
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$0.00
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | |
| Report Date | 2022-05-16 | 2022-08-15 | |
| Assets | |||
| Total Assets | 3.602 M | 2.504 M | |
| Current Assets | 2.323 M | 1.171 M | |
| Inventories | 322.992 K | 315.670 K | |
| Other Current Assets | 667.439 K | 496.989 K | |
| Short Term Investments | 667.439 K | 496.989 K | |
| Total Receivables | 115.845 K | 30.069 K | |
| Current Cash | 1.217 M | 328.012 K | |
| Total Non-current Assets | 1.279 M | 1.333 M | |
| Property Plant Equipment | 151.937 K | 147.923 K | |
| Other Assets | 227.192 K | 227.192 K | |
| Intangible Assets | 801.744 K | 890.564 K | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 3.602 M | 2.504 M | |
| Total liabilities | 6.004 M | 7.037 M | |
| Total current liabilities | 4.900 M | 5.322 M | |
| Accounts Payable | 1.565 M | 2.427 M | |
| Other liabilities | 800.000 K | 700.000 K | |
| Current long term debt | 113.974 K | 0.000 | |
| Long term debt | 0.000 | 720.305 K | |
| Other liabilities | 800.000 K | 700.000 K | |
| Minority interest | 292.518 K | 292.517 K | |
| Total Shareholder equity | -2.402 M | -4.533 M | |
| Common stock | 30.208 M | 30.269 M | |
| Retained earnings | -373.775 M | -376.774 M |